Absentfriend - thanks for the Collingwood gif. Made my day. Might watch some Premiership replays to get my magic juice flowing. I wouldn't think the proportion of obese people at a national level would impact the Phase III results that much. Presumably we will be selecting a similar cohort to partake in the trials, all of which will already have OA and it's then the response of each person to the injections. Maybe others have a better idea of the breakdown of the cohorts to cast light on potential for sub-group variation?
PharmD price target fun, page-73
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $68.29M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.0¢ | $156.2K | 795.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 152244 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 25584 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |